Table 4.
Oneway ANOVA of the coefficient of variation (CV) for the normalized mRNA expression of selected transcripts in five pre-defined endometrial sites obtained from seven cows with clinical endometritis (CE), four with subclinical endometritis (SE), and seven healthy control cows (HC) on days 28 to 34 postpartum.
| Factor | Group | Mean | SD | SEM | CI lower bound | CI upper bound | P |
|---|---|---|---|---|---|---|---|
| PTGS2 | CE | 1.2 | 0.6 | 0.2 | 0.659 | 1.827 | 0.26 |
| SE | 0.94 | 0.2 | 0.1 | 0.693 | 1.192 | ||
| HC | 0.7 | 0.4 | 0.1 | 0.417 | 1.109 | ||
| PTPRC | CE | 0.8 | 0.5 | 0.2 | 0.372 | 1.197 | 0.83 |
| SE | 0.8 | 0.4 | 0.2 | 0.107 | 1.452 | ||
| HC | 0.6 | 0.2 | 0.1 | 0.431 | 0.867 | ||
| CEACAM1 | CE | 0.7 | 0.3 | 0.1 | 0.454 | 1.042 | 0.73 |
| SE | 0.6 | 0.2 | 0.1 | 0.263 | 0.972 | ||
| HC | 0.7 | 0.2 | 0.1 | 0.475 | 0.937 | ||
| IL1A | CE | 1.1 | 0.6 | 0.2 | 0.552 | 1.670 | 0.82 |
| SE | 1.4 | 0.7 | 0.3 | 0.339 | 2.413 | ||
| HC | 1.3 | 0.7 | 0.3 | 0.676 | 1.932 | ||
| IL1B | CE | 1.2 | 0.41 | 0.1 | 0.802 | 1.503 | 0.75 |
| SE | 1.2 | 0.7 | 0.4 | 0.105 | 2.373 | ||
| HC | 1.0 | 0.4 | 0.1 | 0.676 | 1.378 | ||
| CXCL8 | CE | 1.3 | 0.4 | 0.2 | 0.929 | 1.752 | 0.60 |
| SE | 1.3 | 0.5 | 0.21 | 0.487 | 2.045 | ||
| HC | 1.1 | 0.4 | 0.2 | 0.703 | 1.439 | ||
| MUC4 | CE | 0.8 | 0.6 | 0.2 | 0.295 | 1.339 | 0.40 |
| SE | 1.1 | 0.3 | 0.2 | 0.568 | 1.661 | ||
| HC | 0.7 | 0.5 | 0.2 | 0.220 | 1.162 | ||
| MUC16 | CE | 0.6 | 0.3 | 0.1 | 0.339 | 0.877 | 0.94 |
| SE | 0.6 | 0.2 | 0.1 | 0.280 | 0.842 | ||
| HC | 0.6 | 0.2 | 0.1 | 0.426 | 0.739 |
Mean, standard deviation (SD), and standard error of the mean (SEM) of CV. Lower and upper bound of confidence interval (CI) and P-value of multiple comparison (Scheffe test).
PTGS2, prostaglandin-endoperoxide synthase 2; PTPRC, protein tyrosine phosphatase receptor type C; CEACAM1, carcinoembryonic antigen related cell adhesion molecule 1; IL1A, interleukin 1 alpha; IL1B, interleukin 1 beta; CXCL8, C-X-C motif chemokine ligand 8; MUC4, mucin 4; MUC16, mucin 16.